Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoran Antonijevic

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Therapeutic Innovation & Regulatory Science|September 21, 2018
The Impact of Adaptive Design on Portfolio OptimizationZoran Antonijevic
Statistics in Medicine|January 10, 2013
A mathematical model for maximizing the value of phase 3 drug development portfolios incorporating budget constraints and riskNitin R Patel, Suresh Ankolekar, Zoran Antonijevic, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Optimizing Drug Development Programs: Type 2 Diabetes Case StudyZoran Antonijevic, Martin Kimber, David Manner, et al.
Statistical Methods in Medical Research|September 21, 2020
Efficient two-stage sequential arrays of proof of concept studies for pharmaceutical portfoliosLinchen He, Linqiu Du, Zoran Antonijevic, et al.
Paediatric Drugs|October 14, 2022
Innovations in Clinical Development in Rare Diseases of Children and Adults: Small Populations and/or Small PatientsRobert A Beckman, Zoran Antonijevic, Mercedeh Ghadessi, et al.
Statistics in Biopharmaceutical Research|April 3, 2023
Planning for the Next Pandemic: Ethics and Innovation Today for Improved Clinical Trials TomorrowGianna McMillan, Cristiana Mayer, Rui Tang, et al.
Therapeutic Innovation & Regulatory Science|August 24, 2023
Aiding the Adoption of Master Protocols by Optimizing Patient EngagementRaymond A Huml, Deborah Collyar, Zoran Antonijevic, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
A Practical Guide to Data Monitoring Committees in Adaptive TrialsMatilde Sanchez-Kam, Paul Gallo, John Loewy, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Views on Emerging Issues Pertaining to Data Monitoring Committees for Adaptive TrialsZoran Antonijevic, Paul Gallo, Christy Chuang-Stein, et al.
Nature Reviews. Drug Discovery|June 27, 2022
Advancing innovative clinical trials to efficiently deliver medicines to patientsRobert A Beckman, Fanni Natanegara, Pritibha Singh, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Therapeutic Innovation & Regulatory Science|September 21, 2018
The Impact of Adaptive Design on Portfolio OptimizationZoran Antonijevic
Statistics in Medicine|January 10, 2013
A mathematical model for maximizing the value of phase 3 drug development portfolios incorporating budget constraints and riskNitin R Patel, Suresh Ankolekar, Zoran Antonijevic, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Optimizing Drug Development Programs: Type 2 Diabetes Case StudyZoran Antonijevic, Martin Kimber, David Manner, et al.
Statistical Methods in Medical Research|September 21, 2020
Efficient two-stage sequential arrays of proof of concept studies for pharmaceutical portfoliosLinchen He, Linqiu Du, Zoran Antonijevic, et al.
Paediatric Drugs|October 14, 2022
Innovations in Clinical Development in Rare Diseases of Children and Adults: Small Populations and/or Small PatientsRobert A Beckman, Zoran Antonijevic, Mercedeh Ghadessi, et al.
Statistics in Biopharmaceutical Research|April 3, 2023
Planning for the Next Pandemic: Ethics and Innovation Today for Improved Clinical Trials TomorrowGianna McMillan, Cristiana Mayer, Rui Tang, et al.
Therapeutic Innovation & Regulatory Science|August 24, 2023
Aiding the Adoption of Master Protocols by Optimizing Patient EngagementRaymond A Huml, Deborah Collyar, Zoran Antonijevic, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
A Practical Guide to Data Monitoring Committees in Adaptive TrialsMatilde Sanchez-Kam, Paul Gallo, John Loewy, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Views on Emerging Issues Pertaining to Data Monitoring Committees for Adaptive TrialsZoran Antonijevic, Paul Gallo, Christy Chuang-Stein, et al.
Nature Reviews. Drug Discovery|June 27, 2022
Advancing innovative clinical trials to efficiently deliver medicines to patientsRobert A Beckman, Fanni Natanegara, Pritibha Singh, et al.
Pageof 2